Caricamento...
Validation of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA)
BACKGROUND: It has been suggested to replace the diagnosis-specific graded prognostic assessment (DS-GPA, based on performance status and number of brain metastases) for patients with primary malignant melanoma with the new Melanoma-molGPA. The latter is a more complex assessment, which also include...
Salvato in:
| Pubblicato in: | J Clin Med Res |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elmer Press
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5798262/ https://ncbi.nlm.nih.gov/pubmed/29416574 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr3248w |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|